NCT06773715Recruiting
Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain
Changing the View of Pain: Using Virtual Reality As Adjunctive Therapy for Sickle Cell Pain in Pediatric Patients
Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this randomized control clinical trial is to learn if virtual reality can be used to treat sickle cell pain in children. The main questions it aims to answer are: Does virtual reality reduce pain severity during a child's hospital stay for a vaso-occlusive pain crisis? Does virtual reality decrease the daily use of opiates? Researchers will compare standard therapy to the use of standard therapy plus a daily virtual reality experience to see if virtual reality works to treat sickle cell pain. All patients will: \- Be asked to fill out a pain assessment survey three times daily for up to 3 days If randomized to intervention arm, patients will: * Participate in an immersive virtual reality experience once daily for up to 3 days * Fill out a survey twice daily to monitor for side effects from virtual reality experience * Fill out a satisfaction survey once during the study period
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 14 Nov 2024
- Start date
- 12 Sept 2024
- Primary completion date
- 19 Dec 2025
- Lead sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Diseases
- Sickle cell disease
- NCT number
- NCT06773715
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 12 Sept 2024 to the primary completion date, 19 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient has previously participated in the study
Other illness
- Patents upon admission found to have sequela of their sickle cell disease that would require medical therapy greater than the standard of care for a vaso-occlusive pain event. This includes acute chest syndrome, splenic sequestration, post-operative pain, and/or cerebrovascular accident
- Failure to obtain or refusal to provide parental/guardian permission (informed consent) and if appropriate child assent
Age
- Patients aged 7-years-old and younger.
Other
- Patients who are developmentally or cognitively incapable of using VR equipment and answering questions appropriately
- Study team is unable to initiate study interventions within the first 24 hours of a patient's admission
Who the study is looking for
- Patient ≥ 8 up to 21 years of age
- Presenting to CHNOLA ER or outside facility with chief complaint of vaso-occlusive pain crisis, requiring inpatient admission for further pain management
- No known cognitive or neurological deficits
- Parental/guardian permission (informed consent) and if appropriate, child assent.
Age in the registry: 8 years to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital of New Orleans Coordinator of this site? Confirm its status | New Orleans | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.